Paul Upton

15PUBLICATIONS
87CO-AUTHORS
Respiratory diseasesAtomic and molecular physicsMechanobiologyTissue engineeringEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

|Apr 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.

Bin Liu, Mujahid Azfar, Ekaterina Legchenko

|Nov 07, 2022
An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis.

Alexander J Ainscough, Timothy J Smith, Maike Haensel

|Oct 19, 2022
A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?

Paul Upton, Susan Richards, Angela Bates

|Apr 18, 2022
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.

Paul D Upton, Benjamin J Dunmore, Wei Li

|Jan 21, 2022
Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.

Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov

Pageof 3

Frequent Collaborators

8 joint publications

Nick W Morrell

4 joint publications

Martin Wilkins

4 joint publications

John Wharton

3 joint publications

Mark R Toshner